Which ETFs own YMAB?
Y-mAbs Therapeutics, Inc. — 1 ETFs hold it, worth $837.3K across 41.61K shares.
Holdings as of Apr 17, 2023 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | CNCR Loncar Cancer Immunotherapy ETF | 3.12% | 41.61K | $837.3K | $12.7M | Biotech | +1.58% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.